Tibet AIM Pharm. Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022	Dec '20 Dec 31, 2020
Cash & Equivalents	297.68	427.4	385.86	321.28	182.73	205.32
Trading Asset Securities	280	-	-	-	-	-
Cash & Short-Term Investments	577.68	427.4	385.86	321.28	182.73	205.32
Cash Growth	48.93%	10.77%	20.10%	75.83%	-11.00%	8.11%
Accounts Receivable	45.59	52.37	38.29	169.96	44.24	83.29
Other Receivables	2.73	2.97	5.37	31.91	93.17	135.33
Receivables	48.32	55.34	43.66	201.87	137.4	218.62
Inventory	38.72	41.05	58.97	45.55	33.61	20.7
Prepaid Expenses	-	-	-	-	3.29	0
Other Current Assets	7.56	3.82	1.19	6.3	5.14	5.61
Total Current Assets	672.28	527.61	489.67	575.01	362.17	450.25
Property, Plant & Equipment	333.78	344.63	349.15	364.85	378.96	396.15
Long-Term Investments	3.57	3.62	42.57	-	-	-
Goodwill	16.67	16.67	16.67	36.47	36.47	7.67
Other Intangible Assets	19.18	20.7	25.91	31.1	37.25	41.53
Long-Term Deferred Tax Assets	1.63	2	3.51	4.81	2.13	5.68
Long-Term Deferred Charges	-	-	-	1.78	3.57	2.08
Other Long-Term Assets	11.67	11.24	0.26	4.18	3.92	4.73
Total Assets	1,059	926.47	927.74	1,018	824.47	908.09
Accounts Payable	139.05	103.51	106.04	127.01	17.2	39.2
Accrued Expenses	17.21	18.98	14.71	27.23	18.56	19.01
Short-Term Debt	26.77	22.82	11.01	50.05	-	40
Current Income Taxes Payable	20.38	1.87	1.48	4.74	1.4	9.64
Current Unearned Revenue	1.35	3.15	3.51	4.21	9.24	47.38
Other Current Liabilities	46.7	24.78	34.33	48.67	52.94	63.04
Total Current Liabilities	251.46	175.12	171.08	261.91	99.35	218.27
Long-Term Unearned Revenue	5.17	5.78	6.6	4.43	5.02	2.67
Other Long-Term Liabilities	-	-	-	1.86	-	-
Total Liabilities	256.63	180.89	177.68	268.21	104.36	220.94
Common Stock	190.68	190.68	190.68	190.68	191.19	191.77
Additional Paid-In Capital	229.46	232.66	232.66	232.68	234.49	236.39
Retained Earnings	421.65	358.61	318.28	321.96	296.83	269.63
Treasury Stock	-48.15	-50.03	-	-0.02	-5.12	-10.65
Comprehensive Income & Other	8.51	7.08	3.4	-0.01	-0	0.01
Total Common Equity	802.15	739	745.02	745.29	717.39	687.15
Minority Interest	-	6.57	5.04	4.7	2.72	-
Shareholders' Equity	802.15	745.58	750.06	750	720.11	687.15
Total Liabilities & Equity	1,059	926.47	927.74	1,018	824.47	908.09
Total Debt	26.77	22.82	11.01	50.05	-	40
Net Cash (Debt)	550.91	404.58	374.85	271.23	182.73	165.32
Net Cash Growth	45.13%	7.93%	38.20%	48.44%	10.53%	37.87%
Net Cash Per Share	3.05	2.20	1.95	1.41	0.95	0.89
Filing Date Shares Outstanding	187.27	183.47	190.68	190.68	191.19	191.77
Total Common Shares Outstanding	187.27	183.47	190.68	190.68	191.19	191.77
Working Capital	420.82	352.5	318.59	313.1	262.83	231.98
Book Value Per Share	4.28	4.03	3.91	3.91	3.75	3.58
Tangible Book Value	766.3	701.64	702.44	677.72	643.67	637.95
Tangible Book Value Per Share	4.09	3.82	3.68	3.55	3.37	3.33
Buildings	-	349.96	350.18	350.18	350.18	334.36
Machinery	-	106.93	96.49	96.82	92.61	76.01
Construction In Progress	-	-	-	-	2.41	36.7

Source: S&P Global Market Intelligence. Standard template. Financial Sources.